Resource type 'Experimental Assay Type'
Experimental Assay Type
Genomics (4) | Single Cell (0) | Organism or Strain Characteristics (0) | Metabolomics (0) | Proteomics (0) | Immunoassay (0) | Fluxomics (0) | Interactomics (0) | Transcriptomics (1) | Reactomics (0) | Result Dataset of Clinical Study (5) | Image collection (0)
Related resources
44 Resources visible to you, out of a total of 54Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: DENSE-R-CHOP-14
Study: DENSE-R-CHOP-14
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MAXSEP
Study: MAXSEP
Polar test data for individual workpackages with different FHIR structure.
Submitter: Alexander Strübing
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Test Data
Study: FHIR Test Data
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SISPCT
Study: SISPCT
We are releasing the summary data from our GWAMA of PCSK9 levels, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.
Citation: tba
When using this data acknowledge the source as follows: 'Data on PCSK9 has been downloaded from https://www.health-atlas.de/data_files/551.'
For any enquiries about the datasets, please contact Janne Pott (janne.pott@imise.uni-leipzig.de) ...
Submitter: Janne Pott
Resource type: Experimental Assay Type
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAMA PCSK9
Clinical data extracted from local EHR systems.
Submitter: Matthias Löbe
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: FAIR4Health Pathfinder Case Studies
The primary goal of this study was to identify genetic loci associated with steroid hormone levels (cortisol, DHEA-S, testosterone, estradiol, progesterone, 17-hydroxyprogesterone, androstenedione, and aldosterone). In a secondary analysis, we searched for causal effects of steroid hormones on coronary artery disease.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
Study: GWAS Steroid Hormones
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: FLYER
Study: Flyer
To provide data input and result from a scRNA-Seq integration workflow
Submitter: Holger Kirsten
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
We are releasing the summary data from our GWAMA of phytosterol traits, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.
Citation: tba
When using this data acknowledge the source as follows: 'Data on phytosterol X has been contributed by LIFE investigators and has been downloaded from https://www.health-atlas.de/assays/53.'
For any enquiries about ...
Submitter: Janne Pott
Resource type: Experimental Assay Type
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAMA Phytosterole
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: DENSE-R-CHOP-14
Study: DENSE-R-CHOP-14
Submitter: Katrin Horn
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: OMICS Investigations
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-60
Study: RICOVER-60
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-60
Study: RICOVER-60
Submitter: Katrin Horn
Resource type: Gene Expression Profiling
Technology type: Technology Type
Investigation: OMICS Investigations
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-noRTh
Study: RICOVER-noRTh
Allgemein
Alle einzelnen Datensätze sind aufgeteilt in jeweils (maximal) 1000 Patienten, die jeweils als json.zip
und ndjson
verfügbar sind.
Die json.zip
und ndjson
beinhalten jeweils bis zu 1000 Transaktion-Bundles mit jeweils 1 Patienten.
Die gleichnamige Excel-Datei ist die Vorlage zum Generieren JSON-Dateien.
VHF-Testdaten_01
Ursprüngliche Vorhofflimmern (VHF) Testdaten sind Patienten
- unterschiedlichen Alters (17 bis 83 Jahre, davon 3300 Patienten mit Alter > 65 Jahre)
- mit ...
Submitter: Alexander Strübing
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Test Data
Study: FHIR Test Data
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: RICOVER-noRTh
Study: RICOVER-noRTh
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 268
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SEXIE-R-CHOP-14
Study: SEXIE-R-CHOP-14
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 268
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SEXIE-R-CHOP-14
Study: SEXIE-R-CHOP-14
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 189
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SMARTE-R-CHOP-14
Study: SMARTE-R-CHOP-14
Collection of general FHIR test data
Submitter: Alexander Strübing
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Test Data
Study: FHIR Test Data
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 189
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SMARTE-R-CHOP-14
Study: SMARTE-R-CHOP-14
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Pegfilgrastim
Study: Pegfilgrastim
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Pegfilgrastim
Study: Pegfilgrastim
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MInT
Study: MInT
Submitter: Matthias Löbe
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: EHDS in 3LGM²
Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MegaCHOEP
Study: MegaCHOEP
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SISPCT
Study: SISPCT
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MAXSEP
Study: MAXSEP
We are releasing the summary data from our GWAS of carotid plaque burden traits, pending on acceptance of our publication, to empower other researchers to examine variants or loci in which they are interested for associations. These data are intended for research purposes only.
Citation:
When using this data acknowledge the source as follows: 'Data on carotid plaque burden has been contributed by LIFE-Adult investigators and has been downloaded from https://www.health-atlas.de/assays/31 '
For any ...
Submitter: Janne Pott
Resource type: Genome Wide Association
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAS Carotid Plaque Burden
We are releasing the summary data from our meta-analyses of steroid hormones, to empower other researchers to examine variants or loci in which they are interested for association with these hormonal traits. These data are intended for research purposes only.
Citation: Pott et al. (2019) Genetic Association Study of Eight Steroid Hormones and Implications for Sexual Dimorphism of Coronary Artery Disease. J Clin Endocrinol Metab 104: 5008–5023. PubMed ID: 31169883
When using this data acknowledge ...
Submitter: Janne Pott
Resource type: Genome Wide Association
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAS Steroid Hormones
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: head and neck squamous cell carcinomas
Study: HNSCC
Summary Statistics used in publication
Submitter: Katrin Horn
Resource type: Genome Wide Association
Technology type: Technology Type
Investigation: OMICS Investigations
Study: GWAMA vaspin
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: head and neck squamous cell carcinomas
Study: HNSCC
This assay bundles all synthetic FHIR data of the PhenoMan evaluation. The data arised from a subset of a Synthea(TM) generated data set. We truncated some resource types like Encounter and Provider to reduce the size of the data set and to speed up the import in a FHIR health data store.
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: Ontology-based Phenotyping
Summary statistics from GWAS of baPWV, bfPWV, cfPWV All samples (adjusted for age, sex and log_sys)
These data is intended for research purposes only.
Citation: tbc
When using this data acknowledge the source as follows: 'Data on PWV has been contributed by LIFE-Adult investigators and has been downloaded from https://www.health-atlas.de/assays/34'
For any enquiries about the datasets, please contact Michael Rode (michael.rode@imise.uni-leipzig.de) or Markus Scholz (markus.scholz@imise.uni-leipzig.de) ...
Submitter: Michael Rode
Resource type: Genome Wide Association
Technology type: SNP Array
Investigation: OMICS Investigations
Study: GWAS Pulse Wave Velocity
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Covid-19
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Covid-19
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: ACT-2
Study: ACT-2
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: ACT-2
Study: ACT-2
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: FLYER
Study: Flyer